June 8, 2009 - Volume 87, Number 23
- p. 51
Science & Technology
Courtesy of Jason McCarthy
Clots in a mouse artery, lit up by nanoparticles that bind fibrin (top) and factor XIIIa (middle). A composite image (bottom) reveals that factor XIIIa is bound throughout, indicating that the bulk of the clot is newly formed.
More Science & Technology Concentrates
- Methyl-Phosphate H-Bonds
- Methyl and phosphate groups in selenium-derivatized DNA have been brought close enough together to form hydrogen bonds for the first time
- Hydrogen Peroxide Guides Immune Cells
- Leukocytes are imaged rushing to an injury site in response to an H2O2 plume created by a protein called dual oxidase
- Keeping Body Time By Metabolomics
- By 24-hour monitoring of oscillating hormone and metabolite levels, scientists glean information on how to optimize the benefits of medicines
- Specks Mark The Clot
- Iron oxide nanoparticles functionalized with a fluorescent dye and a peptide light up newly formed clots for diagnostic imaging
- Nitrogen Isotopes In Ice Cores Record Human Activity
- A study of ice cores from Greenland reveals that the nitrogen isotope ratio in nitrates has undergone a marked change in the past 300 years
- Gel Formation Induces Organocatalysis
- An L-proline-based compound that forms supramolecular gels also acts as an organocatalyst for the Henry reaction
- Chiral Copper Carbene Catalysts
- Novel dissymmetric imidazolium salts form enantioselective copper-N-heterocyclic carbene catalysts for conjugate addition reactions
- Quasicrystals In Nature
- Search turns up oddly ordered crystalline grains in Al-Cu-Fe minerals
Topics Covered
Iron oxide nanoparticles, when decorated with a fluorescent dye and the right peptide, can drift through blood vessels and light up newly formed clots to determine whether they are good candidates for treatment with thrombolytic drugs, according to a report by Jason R. McCarthy, Farouc A. Jaffer, and coworkers of Massachusetts General Hospital (Bioconjugate Chem., DOI: 10.1021/bc9001163). Removing those blockages with medication is risky because the same drug that clears one blood vessel may trigger serious bleeding in another area, such as the brain. To avoid those tragic side effects, the researchers proposed that functionalized nanoparticles could serve as magnetic resonance imaging contrast agents to help doctors decide whether a patient should receive clot-busting drugs. Bearing the dye molecules, the same nanoparticles make blockages shine for a catheter-based fluorescence microscope that can be used to watch a treated clot dissolve in real time. Key to the strategy, which the researchers tested in mice, is coupling the particles with a peptide that irreversibly binds factor XIIIa, a protein that is found only in fresh clots. The team plans further studies on the nanoparticles to evaluate thrombolytic drugs in vivo and to monitor clot formation on stents.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © 2009 American Chemical Society
Services & Tools
ACS Resources
ACS Careers
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
» Join ACS
Join more than 158,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!
